Treatment Overview
Ovarian cancer screening in Korea is a proactive diagnostic service performed as part of annual gynecology checkups to detect ovarian cancer at the earliest possible stage. Ovarian cancer is often symptomless in its early phases, making screening crucial for prevention and early treatment. Korea’s healthcare system utilizes state-of-the-art diagnostic tools, expert gynecologic oncologists, and integrated care approaches to ensure high accuracy and patient comfort.
Screening generally involves a combination of pelvic examination, transvaginal ultrasound, and blood tests such as CA-125, sometimes supplemented by advanced genetic testing for high-risk patients. Korea’s cutting-edge medical facilities and international-standard protocols make it a leading destination for ovarian cancer prevention.
Purpose & Benefits
The main purpose of ovarian cancer screening is early detection, which significantly increases treatment success rates.
Key benefits include:
- Detection of ovarian cancer in early stages before symptoms develop
- Identification of benign ovarian cysts and other ovarian abnormalities
- Comprehensive risk assessment for women with a family history of ovarian or breast cancer
- Peace of mind through preventive health care
- Personalized follow-up plans if abnormalities are detected
Ideal Candidates
Ovarian cancer screening is recommended for:
- Women over 40 years old, especially after menopause
- Women with a family history of ovarian, breast, or colorectal cancer
- Patients with BRCA1 or BRCA2 gene mutations
- Women experiencing unexplained abdominal pain, bloating, or irregular periods
- Women undergoing annual gynecological checkups for preventive care
Possible Risks & Complications
Ovarian cancer screening is generally safe, but certain considerations include:
- Minor discomfort during transvaginal ultrasound
- Anxiety while awaiting results
- False positives that may require further testing
- Rarely, invasive follow-up procedures such as laparoscopy or biopsy may be recommended
Surgical Techniques Used
Ovarian cancer screening itself is non-surgical, but if abnormalities are detected, advanced surgical techniques in Korea may be employed:
- Laparoscopic Surgery – Minimally invasive removal of suspicious ovarian masses
- Robotic-Assisted Surgery – Enhanced precision for ovarian cyst removal and staging
- Fertility-Sparing Surgery – For young women diagnosed early who wish to preserve reproductive potential
- Complete Cytoreductive Surgery – For advanced ovarian cancer management
Screening in Korea often combines high-resolution transvaginal ultrasound with AI-assisted imaging to improve early detection accuracy.
Recovery & Aftercare
Ovarian cancer screening requires no downtime. If surgery is needed, recovery time varies depending on the procedure:
- Laparoscopic surgery: 1–2 weeks
- Robotic-assisted surgery: 2–3 weeks
- Open surgery (laparotomy): 4–6 weeks
Aftercare includes regular follow-ups, repeat imaging, and, if needed, chemotherapy or hormone therapy depending on diagnosis.
Results & Longevity
Screening results from transvaginal ultrasound and CA-125 blood tests are typically available within a few days. For high-risk patients, genetic testing results may take 1–2 weeks.
Early detection through regular screening significantly improves prognosis and can prolong survival rates. For women with increased genetic risk, ongoing annual screening is strongly recommended.
Treatment Process in Korea
Korea offers a structured ovarian cancer screening process:
- Consultation & Risk Assessment – Review of personal and family medical history, symptoms, and risk factors.
- Pelvic Examination – Manual and visual examination of the reproductive organs.
- Transvaginal Ultrasound – High-resolution imaging of the ovaries and pelvic cavity.
- Blood Tests – CA-125, HE4, and other tumor markers if indicated.
- Genetic Testing – For women with high familial risk.
- Result Interpretation & Follow-Up – Detailed explanation of findings with a tailored follow-up plan.
Unique Korean strengths:
- Integration of AI-assisted ultrasound technology for precise detection
- Advanced genetic testing for ovarian cancer risk stratification
- Specialized ovarian cancer centers offering comprehensive screening and treatment
- Multilingual support for international patients with quick and efficient service
Cost Range
Ovarian cancer screening costs in Korea vary depending on the scope of testing:
- Basic screening (pelvic exam + transvaginal ultrasound): KRW 150,000 – 300,000 (USD 110 – 220)
- Screening with CA-125 blood test: KRW 300,000 – 500,000 (USD 220 – 370)
- Comprehensive screening package (including genetic testing): KRW 800,000 – 1,500,000 (USD 600 – 1,100)
High-risk patients may require ongoing annual screening for optimal preventive care.
Popular Clinics
- Samsung Medical Center, Seoul – Advanced ovarian cancer screening and genetic testing programs.
- Asan Medical Center, Seoul – Comprehensive women’s cancer prevention center with specialized gynecologic oncology services.
- Severance Hospital (Yonsei University), Seoul – Known for state-of-the-art imaging and ovarian cancer screening.
- CHA Medical Center, Seoul – Focus on reproductive health and preventive gynecology.
- Gangnam Severance Health Check-Up Center – Premium ovarian cancer screening packages tailored for international patients.
